Head-to-head · Cost-Efficiency Index
SnagRx vs Teleios Health
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
SnagRx
Shoppers who want a specifically-named compounding pharmacy but should confirm the promo price won't expire.
Visit SnagRxTeleios Health
Shoppers comfortable calling or messaging before committing, since public pricing detail is minimal.
Visit Teleios HealthThe verdict
SnagRx and Teleios Health tie on the Cost-Efficiency Index at 65/100, so neither wins outright on the numbers. For most shoppers we'd start with SnagRx (ranked #169, a hair above #170) — Shoppers who want a specifically-named compounding pharmacy but should confirm the promo price won't expire. But Teleios Health is a genuine coin-flip alternative here.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs SnagRx.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | SnagRx | Teleios Health |
|---|---|---|
| Cost-Efficiency Index | 65/100 | 65/100 |
| Semaglutide / mo | $99/mo (flat at every dose, compounded) | $99/mo (all doses, compounded) |
| Tirzepatide / mo | $149/mo (flat at every dose, compounded) | Not disclosed |
| Semaglutide / yr (modeled) | $828 | $1,188 |
| Tirzepatide / yr (modeled) | $1,428 | — |
| Coverage | All 50 states plus Washington D.C. (per Terms) | Coverage not published |
| Oral / sublingual | No | No |
| Brand-name access | Compounded only | Compounded only |
| Rank here | #169 | #170 |
SnagRx
65/100Where the value is
- Names four specific, checkable compounding pharmacy partners
- Broad state coverage (48 states, only MS and LA excluded)
- Displays a LegitScript badge and claims certification
The tradeoffs
- Headline prices are shown against a struck-through 'regular price' -- classic promo-pricing signal, not confirmed as permanent
- Medical director exists but is not named
Teleios Health
65/100Where the value is
- Advertises a low $99/mo headline starting price, undercutting most compounded-GLP-1 competitors on paper
- Explicitly brands itself as 'physician-led,' setting an expectation of clinician oversight
- Discloses the standard compounded-medication FDA disclaimer up front rather than burying it
The tradeoffs
- No dose amount, drug, or inclusion breakdown is published for the $99/mo figure
- No visit fee, membership fee, or shipping fee disclosure could be found anywhere on the site
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.